Back to search
Sepsis-associated AKI
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sepsis-associated AKI trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Sepsis-associated AKI trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Sepsis is a leading cause of acute kidney injury (AKI) in critically ill patients, with sepsis-associated AKI accounting for approximately 50% of all AKI cases…
This multicenter, randomized, open-label, active-controlled, parallel-group trial will evaluate the efficacy and safety of nafamostat mesylate anticoagulation c…